Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation

References

• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• Chichester CO, Fernandez M, Minguell JJ. Extracellular matrix gene expression by human bone marrow stroma and by marrow fibroblasts. Cell Adhes Commun. 1993;1:93–9.
   PubMed Web of Science ®Google Scholar
• Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30:42–8.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31:890–6.
   PubMed Web of Science ®Google Scholar
• Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation. 2003;76:1208–13.
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;15:1815–22.
   Google Scholar
• Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, Haynesworth SE, Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 2004;33:597–604.
   PubMed Web of Science ®Google Scholar
• Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res. 2005;305:33–41.
   PubMed Web of Science ®Google Scholar
• Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation. 2003;75:389–97.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439–41.
   PubMed Web of Science ®Google Scholar
• Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 2006;81:1390–7.
   PubMed Web of Science ®Google Scholar
• Deng W, Han Q, Liao L, Li C, Ge W, Zhao Z, Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp Hematol. 2004;32:861–7.
   PubMed Web of Science ®Google Scholar
• Pan H, Zhao K, Wang L, Zheng Y, Zhang G, Mai H, Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. J Surg Res. 2010;160:315–24.
   Google Scholar
• Lakey JR, Mirbolooki M, Shapiro AM. Current status of clinical islet cell transplantation. Methods Mol Biol. 2006;333:47–104.
   PubMedGoogle Scholar
• Moberg L, Johansson H, Lukinius A, Berne C, Foss A, Kallen R, Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet. 2002;360:2039–45.
   PubMed Web of Science ®Google Scholar
• Johansson H, Lukinius A, Moberg L, Lundgren T, Berne C, Foss A, Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes. 2005;54:1755–62.
   PubMed Web of Science ®Google Scholar
• Eich T, Eriksson O, Sundin A, Estrada S, Brandhorst D, Brandhorst H, Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation. 2007;84:893–8.
   PubMed Web of Science ®Google Scholar
• Li H, Fu X, Ouyang Y, Cai C, Wang J, Sun T. Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res. 2006;326:725–36.
   PubMed Web of Science ®Google Scholar
• Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H, Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 2006;12:459–65.
   PubMed Web of Science ®Google Scholar
• Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg. 2002;73:1919–25; discussion 26.
   PubMed Web of Science ®Google Scholar
• Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005;289:31–42.
   PubMed Web of Science ®Google Scholar
• Seeberger KL, Dufour JM, Shapiro AM, Lakey JR, Rajotte RV, Korbutt GS. Expansion of mesenchymal stem cells from human pancreatic ductal epithelium. Lab Invest. 2006;86:141–53.
   PubMed Web of Science ®Google Scholar
• Johansson U, Elgue G, Nilsson B, Korsgren O. Composite islet-endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation. Am J Transplant. 2005;5:2632–9.
   PubMedGoogle Scholar
• Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes. 1988;37:413–20.
   PubMed Web of Science ®Google Scholar
• Brandhorst H, Brandhorst D, Brendel MD, Hering BJ, Bretzel RG. Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant. 1998;7:489–95.
   Google Scholar
• Lakey JR, Warnock GL, Shapiro AM, Korbutt GS, Ao Z, Kneteman NM, Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant. 1999;8:285–92.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003;57:11–20.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.
   PubMed Web of Science ®Google Scholar
• Rivkin R, Ben-Ari A, Kassis I, Zangi L, Gaberman E, Levdansky L, High-yield isolation, expansion, and differentiation of murine bone marrow-derived mesenchymal stem cells using fibrin microbeads (FMB). Cloning Stem Cells. 2007;9:157–75.
   PubMedGoogle Scholar
• Workman P, Balmain A, Hickman JA, McNally NJ, Rohas AM, Mitchison NA, UKCCCR guidelines for the welfare of animals in experimental neoplasia. Lab Anim. 1988;22:195–201.
   Google Scholar
• Gong J, Larsson R, Ekdahl KN, Mollnes TE, Nilsson U, Nilsson B. Tubing loops as a model for cardiopulmonary bypass circuits: both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model. J Clin Immunol. 1996;16:222–9.
   PubMed Web of Science ®Google Scholar
• Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells. 2009;27:2614–23.
   PubMed Web of Science ®Google Scholar
• Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001;169:12–20.
   PubMed Web of Science ®Google Scholar
• Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003;108:863–8.
   PubMed Web of Science ®Google Scholar
• Togel F, Yang Y, Zhang P, Hu Z, Westenfelder C. Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am J Physiol Renal Physiol. 2008;295:315–21.
   Google Scholar
• Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med. 2004;14:1035–41.
   PubMed Web of Science ®Google Scholar
• Johansson U, Rasmusson I, Niclou SP, Forslund N, Gustavsson L, Nilsson B, Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes. 2008;57:2393–401.
   PubMed Web of Science ®Google Scholar
• Figliuzzi M, Cornolti R, Perico N, Rota C, Morigi M, Remuzzi G, Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. Transplant Proc. 2009;41:1797–800.
   PubMed Web of Science ®Google Scholar
• Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res. 2006;312:2169–79.
   PubMed Web of Science ®Google Scholar
• Markmann JF, Bassiri HF, Barker CF, Naji A. Effect of lymphokine-induced MHC antigen expression on islet allograft survival. Transplant Proc. 1989;21:2723–4.
   Google Scholar
• Sever CE, Demetris AJ, Zeng Y, Carroll P, Tzakis A, Starzl TE, Cellular composition of islet cell suspensions for transplantation. Transplant Proc. 1992;24:979.
   Google Scholar
• Johansson U, Olsson A, Gabrielsson S, Nilsson B, Korsgren O. Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun. 2003;308:474–9.
   PubMed Web of Science ®Google Scholar
• Swift SM, Rose S, London NJ, James RF. Development and optimization of the human allogeneic mixed lymphocyte islet (MLIC) and acinar (MLAC) coculture system. Transpl Immunol. 1996;4:169–76.
   Google Scholar
• Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, La Rosa S, Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol. 2009;183:993–1004.
   PubMed Web of Science ®Google Scholar
• Itakura S, Asari S, Rawson J, Ito T, Todorov I, Liu CP, Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat. Am J Transplant. 2007;7:336–46.
   Google Scholar
• Friedenstein AJ, Piatetzky S II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966;16:381–90.
   PubMedGoogle Scholar
• Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone. 1992;13:81–8.
   PubMed Web of Science ®Google Scholar